PM Modi inaugurates Lyfius Pharma Penicillin-G Facility in AP

Kakinada: Lyfius Pharma, a wholly owned step-down subsidiary of Aurobindo Pharma has announced the inauguration of its state-of-the-art PenG manufacturing facility, at Kakinada, Andhra Pradesh. With an annual production capacity of 15,000 metric
tonnes (MT), the facility was virtually inaugurated by Hon’ble Prime Minister Shri. Narendra Modi in the
presence of Jagat Prakash Nadda (Union Minister of Chemicals & Fertilizers, Health & Family Welfare),
Dr. Mansukh Mandaviya (Union Minister of Labour & Employment, Youth Affairs & Sports), Smt. Anupriya
Patel (Union MoS Chemicals & Fertilizers, Health & Family Welfare), Shri. Prataprao Jadhav (Union MoS (IC)
Ayush, MoS Health & Family Welfare) and Sushri Shobha Karandlaje (Union MoS Labour & Employment,
Micro, Small & Medium Enterprises).

This facility represents a strategic investment of ₹2,500 crores, under the Government of India’s PLI Scheme,
and exemplifies how private sector participation can significantly contribute to national growth, drive
innovation, and enhance healthcare security.
The PLI scheme for the pharmaceutical sector aims to
strengthen domestic manufacturing capabilities in critical KSMs, DIs, and APIs.
Commenting on the occasion, Mr. M.V. Rama Krishna, Director Lyfius Pharma, said “The launch of our PenG facility is a significant milestone in our efforts to enhance local production and reduce import dependency
for critical pharmaceutical ingredients. This investment underscores our commitment to support the
government’s vision of ‘Atmanirbhar Bharat’, establishing India as a global pharmaceutical manufacturing
hub.”

Lyfius Pharma is engaged in the manufacturing of Penicillin-G. Its state-of-art facility is situated at Kakinada, Andhra Pradesh, approved under the PLI (Production Linked Incentive) scheme.

Read also: Aurobindo Pharma to acquire balance 49 percent stake in GLS Pharma for Rs 22.5 crores

Facebook Comments